Advancements in Tuberculosis Detection: A Comprehensive Review of Contemporary Diagnostic Strategies
OthersPage Navigation
Introduction
With the persistent global burden of Tuberculosis (TB), early and accurate detection remains a cornerstone in combating this disease. The recent years have seen significant advancements in TB diagnostic strategies, enhancing the efficiency of detection and management.
GeneXpert MTB/RIF
Introduced by Cepheid, the GeneXpert MTB/RIF system has revolutionized TB diagnosis. This automated, cartridge-based nucleic acid amplification test provides results within two hours, identifying Mycobacterium tuberculosis complex and rifampicin resistance simultaneously.
Line Probe Assays
World Health Organization-endorsed Line Probe Assays (LPAs) have been instrumental in detecting drug-resistant TB. LPAs allow for rapid identification of resistance to rifampicin and isoniazid, the two most potent first-line anti-TB drugs.
Next-Generation Sequencing
Next-Generation Sequencing (NGS) provides comprehensive genetic information, enabling the detection of drug resistance and strain typing. NGS's high-throughput capabilities make it a promising tool for TB diagnostics.
Conclusion
These advancements in TB detection have propelled us closer to the goal of TB elimination. However, the challenge of accessibility and cost-effectiveness in resource-limited settings persists. Continued innovation and investment in diagnostic strategies are essential to curb the global TB epidemic.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
Asian Women With Breast Cancer Outlive White Peers
4.
What Comes After Cancer?
5.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
1.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
2.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Diagnosis and Management in Hematology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge